LW
LH icon

Linscomb Wealth’s Labcorp LH Stock Holding History

Linscomb Wealth’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.44M Sell
12,899
-2,841
-18% -$769K 0.15% 120
2025
Q4 		$3.95M Buy
15,740
+364
+2% +$96.7K 0.17% 116
2025
Q3 		$4.41M Buy
15,376
+501
+3% +$134K 0.19% 107
2025
Q2 		$3.9M Buy
14,875
+752
+5% +$183K 0.18% 110
2025
Q1 		$3.29M Buy
14,123
+584
+4% +$142K 0.16% 114
2024
Q4 		$3.1M Buy
13,539
+389
+3% +$89.2K 0.15% 113
2024
Q3 		$2.94M Buy
13,150
+106
+0.8% +$23.3K 0.15% 115
2024
Q2 		$2.65M Buy
13,044
+57
+0.4% +$11.6K 0.14% 119
2024
Q1 		$2.84M Buy
12,987
+197
+2% +$43.4K 0.15% 113
2023
Q4 		$2.91M Sell
12,790
-193
-1% -$40.5K 0.16% 111
2023
Q3 		$2.61M Sell
12,983
-2,468
-16% -$521K 0.15% 111
2023
Q2 		$3.2M Sell
15,451
-456
-3% -$88.5K 0.17% 105
2023
Q1 		$3.14M Buy
15,907
+106
+0.7% +$21.8K 0.16% 108
2022
Q4 		$3.2M Sell
15,801
-732
-4% -$143K 0.16% 111
2022
Q3 		$2.91M Buy
16,533
+130
+0.8% +$26.6K 0.18% 102
2022
Q2 		$3.3M Sell
16,403
-165
-1% -$35.2K 0.19% 98
2022
Q1 		$3.75M Buy
16,568
+337
+2% +$79.3K 0.18% 99
2021
Q4 		$4.38M Sell
16,231
-170
-1% -$42.1K 0.21% 89
2021
Q3 		$3.96M Buy
16,401
+600
+4% +$151K 0.2% 95
2021
Q2 		$3.75M Buy
15,801
+487
+3% +$111K 0.19% 96
2021
Q1 		$3.35M Buy
15,314
+778
+5% +$156K 0.18% 97
2020
Q4 		$2.54M Buy
14,536
+391
+3% +$67.5K 0.15% 104
2020
Q3 		$2.29M Buy
14,145
+999
+8% +$158K 0.16% 102
2020
Q2 		$1.88M Buy
13,146
+5,082
+63% +$703K 0.14% 102
2020
Q1 		$876K Buy
8,064
+2,060
+34% +$297K 0.08% 157
2019
Q4 		$873K Buy
6,004
+373
+7% +$53.9K 0.06% 246
2019
Q3 		$813K Buy
5,631
+67
+1% +$9.78K 0.07% 139
2019
Q2 		$826K Buy
5,564
+260
+5% +$36.3K 0.07% 138
2019
Q1 		$697K Buy
5,304
+1,521
+40% +$187K 0.06% 146
2018
Q4 		$411K Sell
3,783
-116
-3% -$15.5K 0.04% 181
2018
Q3 		$582K Sell
3,899
-12
-0.3% -$1.82K 0.05% 168
2018
Q2 		$603K Buy
3,911
+45
+1% +$6.79K 0.05% 159
2018
Q1 		$537K Sell
3,866
-31
-0.8% -$4.55K 0.05% 162
2017
Q4 		$534K Buy
3,897
+142
+4% +$18.8K 0.04% 163
2017
Q3 		$487K Buy
3,755
+44
+1% +$5.87K 0.04% 176
2017
Q2 		$491K Hold
3,711
– – 0.04% 167
2017
Q1 		$457K Buy
3,711
+86
+2% +$10.2K 0.04% 173
2016
Q4 		$400K Hold
3,625
– – 0.04% 186
2016
Q3 		$428K Buy
3,625
+48
+1% +$5.66K 0.04% 177
2016
Q2 		$400K Buy
3,577
+97
+3% +$10.4K 0.04% 178
2016
Q1 		$350K Sell
3,480
-312
-8% -$29.9K 0.04% 189
2015
Q4 		$403K Sell
3,792
-874
-19% -$90.2K 0.05% 180
2015
Q3 		$435K Buy
4,666
+224
+5% +$23.2K 0.05% 176
2015
Q2 		$463K Buy
4,442
+33
+0.7% +$3.44K 0.05% 175
2015
Q1 		$478K Buy
+4,409
New +$453K 0.05% 178

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Linscomb Wealth's LH Position: Q1 2026 in Review

Linscomb Wealth reduced its Labcorp (LH) stake by 18% in Q1 2026, selling an estimated $769K and leaving 12,899 shares worth $3.44M. The position accounts for 0.15% of the portfolio, ranked #120.

Linscomb Wealth first reported a position in LH in Q1 2015 and has held it in 45 quarters since. The position peaked at $4.41M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Linscomb Wealth held 12,899 shares of Labcorp worth $3.44M as of Q1 2026.
  • Linscomb Wealth sold 2,841 Labcorp shares in Q1 2026, an estimated $769K.
  • Labcorp made up 0.15% of Linscomb Wealth's portfolio in Q1 2026, its #120 holding.
  • Linscomb Wealth first reported a position in Labcorp in Q1 2015 and has held it in 45 quarters since.
  • Linscomb Wealth's Labcorp position peaked at $4.41M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Linscomb Wealth's 13F filing for Q1 2026, filed 11 May 2026.